review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0889-8529(01)00002-0 |
P698 | PubMed publication ID | 12055991 |
P2093 | author name string | Elizabeth A Young | |
Ania Korszun | |||
P2860 | cites work | Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 |
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites | Q34255972 | ||
Loss of Glucocorticoid Fast Feedback in Depression | Q34501160 | ||
Acute changes in serum gonadotrophins and steroids following orchidectomy in the rat: role of the adrenal gland | Q34733849 | ||
Neuromodulatory regulation of gonadotropin-releasing hormone pulsatile discharge in women | Q37991759 | ||
Successful Treatment of Severe Premenstrual Syndrome by Combined Use of Gonadotropin-Releasing Hormone Agonist and Estrogen/Progestin* | Q38515352 | ||
Models for the development and expression of symptoms in premenstrual syndrome. | Q38621363 | ||
Sex Differences and the Epidemiology of Depression | Q39617578 | ||
Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing Hormone | Q39625743 | ||
Thyroid hormones and TSH, prolactin and LH responses to repeated TRH and LRH injections in depressed patients | Q39674705 | ||
Studies on Pituitary Hormones and Releasing Hormones in Depression and Sexual Impotence | Q39751963 | ||
Population density and reproductive efficiency | Q39894246 | ||
Toward a biology of affective disorders. Genetic contributions | Q40001108 | ||
Endogenous opioid peptides and the control of the menstrual cycle | Q40080161 | ||
Reduced Plasma LH Concentration in Postmenopausal Depressed Women | Q41072014 | ||
TSH and LH Responses in Subtypes of Depression* | Q41087797 | ||
Prospective study of postpartum blues. Biologic and psychosocial factors | Q41168239 | ||
Dexamethasone treatment prevents the inhibitory effect of corticotropin-releasing hormone on gonadotropin release in the primate | Q41261122 | ||
Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey | Q41384188 | ||
Hypothalamic-pituitary-gonadal axis in major depressive disorders | Q41392200 | ||
Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients | Q41561553 | ||
A role for estradiol in enhancing luteinizing hormone pulse frequency during the follicular phase of the estrous cycle of sheep | Q41592264 | ||
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications | Q42508360 | ||
Effects of glucocorticoids on secretion of luteinizing hormone and follicle-stimulating hormone by female rat pituitary cells in vitro | Q42527958 | ||
Cortisol regulates secretion and pituitary content of the two gonadotropins differentially in female rats: effects of gonadotropin-releasing hormone antagonist | Q44002383 | ||
Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate | Q44348498 | ||
The inhibitory action of corticotropin-releasing hormone on gonadotropin secretion in the ovariectomized rhesus monkey is not mediated by adrenocorticotropic hormone | Q69833889 | ||
Increased cortisol production in women runners | Q70140366 | ||
Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion | Q70485177 | ||
Gonadotropin release after administration of GnRH in depressed patients and healthy volunteers | Q70562621 | ||
Neuroendocrine aspects of primary endogenous depression--XIV. Gonadotropin secretion in female patients and their matched controls | Q70959197 | ||
Postpartum psychoses in patients with manic depressive disease | Q71453775 | ||
A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility | Q71465909 | ||
Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression | Q72394618 | ||
Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids | Q72720415 | ||
Glucocorticoid repression of gonadotropin-releasing hormone gene expression and secretion in morphologically distinct subpopulations of GT1-7 cells | Q73695036 | ||
Estrogen replacement in perimenopause-related depression: a preliminary report | Q74171998 | ||
Testosterone, gonadotropin, and cortisol secretion in male patients with major depression | Q77878265 | ||
Hypercortisolism in patients with functional hypothalamic-amenorrhea | Q44492567 | ||
Gender differences in treatment response to sertraline versus imipramine in chronic depression | Q44875491 | ||
The GnRH pulse generator | Q44905771 | ||
The prediction of major depression in women: toward an integrated etiologic model | Q45091884 | ||
The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics | Q45230125 | ||
Neuroendocrine aberrations in women with functional hypothalamic amenorrhea | Q46446093 | ||
Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women | Q46590787 | ||
Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients | Q47208531 | ||
Influence of weight loss on the dexamethasone suppression test | Q47254436 | ||
Effects of weight loss on the dexamethasone suppression test | Q47256796 | ||
Immunocytochemical evidence for direct synaptic connections between corticotrophin-releasing factor (CRF) and gonadotrophin-releasing hormone (GnRH)-containing neurons in the preoptic area of the rat. | Q48122005 | ||
Effects of hydrocortisone on pulsatile pituitary glycoprotein secretion | Q48196608 | ||
Steroids and neuroendocrine function in anorexia nervosa | Q48249965 | ||
Corticotropin-releasing factor (CRF) inhibits gonadotropin-releasing hormone (GnRH) release from superfused rat hypothalami in vitro | Q48321718 | ||
Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction | Q48367125 | ||
GnRH release from the mediobasal hypothalamus: in vitro inhibition by corticotropin-releasing factor | Q48415645 | ||
Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation | Q48440714 | ||
Cortisol secretion in endogenous depression. II. Time-related functions | Q48456202 | ||
Pituitary-adrenal axis rhythm disturbances in psychiatric depression. | Q48459415 | ||
Inhibition of Luteinizing Hormone Secretion Induced by Synthetic LRH by Long-term Treatment with Glucocorticoids in Human Subjects | Q48463579 | ||
Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle | Q48489197 | ||
Sex differences in biological factors putatively related to depression | Q48598255 | ||
The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes | Q48880425 | ||
Neuroendocrinological investigations during sleep deprivation in depression. I. Early morning levels of thyrotropin, TH, cortisol, prolactin, LH, FSH, estradiol, and testosterone | Q48920111 | ||
Amenorrhoea in the Feeding Disorders: Anorexia Nervosa and Obesity | Q48942719 | ||
Tonic and dynamic gonadotropin secretion in depressive and normothymic phases of affective disorders | Q48963060 | ||
The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness | Q49037226 | ||
Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients | Q49093780 | ||
Influence of Adrenocorticotropin and Adrenalectomy on Gonadotropin Secretion in Immature Rats | Q49112397 | ||
Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea | Q49122740 | ||
Alteration in the hypothalamic-pituitary-ovarian axis in depressed women | Q49156226 | ||
Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. | Q50865764 | ||
Lack of effect of induced menses on symptoms in women with premenstrual syndrome. | Q51160096 | ||
Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. | Q51201974 | ||
The influence of dieting on the menstrual cycle of healthy young women. | Q51638045 | ||
Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. | Q52091345 | ||
Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy | Q58449421 | ||
Different reactivity of the hypothalamo-pituitary-gonadal-axis in depression and normal controls | Q67249037 | ||
Response of plasma endorphins, corticotropin, Cortisol, and luteinizing hormone in the corticotropin-releasing hormone stimulation test in eumenorrheic and amenorrheic athletes | Q67912707 | ||
Acute Activation of the Adrenocorticotropin-Adrenal Axis: Effect on Gonadotropin and Prolactin Secretion in the Female Rat* | Q67915550 | ||
Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies | Q68416371 | ||
Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation | Q68928184 | ||
Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls | Q68982294 | ||
Acute inhibition of gonadotropin secretion by corticotropin-releasing hormone in the primate: are the adrenal glands involved? | Q69182079 | ||
Neuroendocrine aspects of primary endogenous depression VIII. Pituitary-gonadal axis activity in male patients and matched control subjects | Q69217683 | ||
Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression | Q69469970 | ||
Social support, life events, and depression during pregnancy and the puerperium | Q69505808 | ||
Premenstrual changes and changes in gonadal hormones | Q69771425 | ||
Plasma corticotropin-releasing hormone, corticotropin, and endorphins at rest and during exercise in eumenorrheic and amenorrheic athletes | Q69832993 | ||
P433 | issue | 1 | |
P304 | page(s) | 63-78 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
P1476 | title | The hypothalamic-pituitary-gonadal axis in mood disorders | |
P478 | volume | 31 |
Q30361004 | 17β-estradiol differentially regulates stress circuitry activity in healthy and depressed women. |
Q36329411 | 3alpha-hydroxy-5alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors |
Q37343584 | A new logical insight and putative mechanism behind fluoxetine-induced amenorrhea, hyperprolactinemia and galactorrhea in a case series |
Q36428962 | A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior |
Q36759146 | Adult female wildtype, but not oestrogen receptor beta knockout, mice have decreased depression-like behaviour during pro-oestrus and following administration of oestradiol or diarylpropionitrile |
Q42649712 | Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity |
Q48060692 | Antidepressant-Like Effect of Ropren® in β-Amyloid-(25-35) Rat Model of Alzheimer's Disease with Altered Levels of Androgens |
Q48197578 | Antisense oligodeoxynucleotides for estrogen receptor-beta and alpha attenuate estradiol's modulation of affective and sexual behavior, respectively |
Q33870790 | Association of serum vitamin D with symptoms of depression and anxiety in early pregnancy |
Q41663438 | Comparison of the effects of PMDD and pre-menstrual syndrome on mood disorders and quality of life: a cross-sectional study |
Q37517285 | Depression and antidepressants: molecular and cellular aspects. |
Q35561671 | Depressive symptoms and risk of uterine leiomyomata. |
Q92646626 | Differential gene expression profile analysis in corticosterone-treated PC12 cells |
Q44799131 | Diurnal rhythms of free estradiol and cortisol during the normal menstrual cycle in women with major depression |
Q36168998 | Dysautonomia in autism spectrum disorder: case reports of a family with review of the literature |
Q38521924 | Effects of psychological stress on male fertility |
Q36091591 | Endocrine disturbances in depression |
Q34148910 | Fetal hormonal programming of sex differences in depression: linking women's mental health with sex differences in the brain across the lifespan |
Q48292059 | Fluoxetine signature on hippocampal MAPK signalling in sex-dependent manner |
Q33470869 | Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder |
Q24657105 | Genetic, epigenetic and environmental impact on sex differences in social behavior |
Q37169827 | HPA-axis hormone modulation of stress response circuitry activity in women with remitted major depression |
Q38166682 | Harmful effects of functional hypercortisolism: a working hypothesis. |
Q35182078 | Hepatocyte nuclear factor 4 alpha is a key factor related to depression and physiological homeostasis in the mouse brain |
Q39624292 | Male-specific effects of lipopolysaccharide on glucocorticoid receptor nuclear translocation in the prefrontal cortex of depressive rats |
Q49602618 | Membrane-initiated estrogen signaling via Gq-coupled GPCR in the central nervous system |
Q58698614 | Mental health, psychotropic medication use, and menstrual cycle characteristics |
Q37402648 | Metabolic assessment of menstruating and nonmenstruating normal weight adolescents |
Q37733065 | Modifications of anxiety-like behavior in prenatally stressed male offspring with imbalance of androgens |
Q36951416 | Mood disorders and fertility in women: a critical review of the literature and implications for future research |
Q37260128 | Neurobiology of major depressive disorder |
Q83927019 | Neuroendocrine responses to psychological stress in eumenorrheic and oligomenorrheic women |
Q47794238 | Ovarian hormones modify anxiety behavior and glucocorticoid receptors after chronic social isolation stress |
Q38062782 | Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-γ systems |
Q38792679 | Preclinical sex differences in depression and antidepressant response: Implications for clinical research |
Q90685453 | Predictors of Depressive Relapse in Women Undergoing Infertility Treatment |
Q33718564 | Sex-based Association between Depression and Metabolic Syndrome in Korean Middle-aged and Older Adults |
Q24309446 | Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity |
Q37135443 | Systemic illness |
Q42691159 | Testosterone promotes anxiolytic-like behavior in gonadectomized male rats via blockade of the 5-HT1A receptors |
Q39263251 | The cytokine-hormone axis - the link between premenstrual syndrome and postpartum depression. |
Q48181913 | The influence of social subordinate housing on the withdrawal effects from progesterone and estradiol in male rats |
Q46534870 | The pattern of growth hormone secretion during the menstrual cycle in normal and depressed women |
Q30475462 | Update on research and treatment of premenstrual dysphoric disorder |
Search more.